Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma

JAMA Oncology

Volumn 2, Issue 6, 2016, Pages 782-789

  Grossberg, Aaron J ^a   Chamchod, Sasikarn ^a,b   Fuller, Clifton D ^a   Mohamed, Abdallah S R ^a,c   Heukelom, Jolien ^d   Eichelberger, Hillary ^e   Kantor, Michael E ^a   Hutcheson, Katherine A ^a   Gunn, G Brandon ^a   Garden, Adam S ^a   Frank, Steven ^a   Phan, Jack ^a   Beadle, Beth ^a   Skinner, Heath D ^a   Morrison, William H ^a   Rosenthal, David I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CHULABHORN GRADUATE INSTITUTE   (Thailand)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIOASSAY; BODY COMPOSITION; BODY MASS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CARCINOMA, SQUAMOUS CELL; ENDPOINT DETERMINATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85010915192     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.6339     Document Type: Article

References (29)

1. Jager-Wittenaar H, Dijkstra PU, Vissink A, et al. Changes in nutritional status and dietary intake during and after head and neck cancer treatment. Head Neck. 2011;33(6):863-870.
2. JacksonW, Alexander N, Schipper M, Fig L, Feng F, Jolly S. Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry. Head Neck. 2014;36(9):1356-1362.
3. Garg S, Yoo J, Winquist E. Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review. Support Care Cancer. 2010;18(6):667-677.
4. Ghadjar P, Hayoz S, Zimmermann F, et al; Swiss Group for Clinical Cancer Research (SAKK). Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94). Radiat Oncol. 2015;10:21.
5. Langius JA, Bakker S, Rietveld DH, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer. 2013;109(5):1093-1099.
6. Karnell LH, Sperry SM, Anderson CM, Pagedar NA. Influence of body composition on survival in patients with head and neck cancer [published online December 24, 2014]. Head Neck. doi:10.1002/hed.23983.
7. Silver HJ, DietrichMS, Murphy BA. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck. 2007;29(10): 893-900.
8. Grossberg AJ, Scarlett JM, Marks DL. Hypothalamic mechanisms in cachexia. Physiol Behav. 2010;100(5):478-489.
9. Prado CM, Lieffers JR,McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7): 629-635.
10. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013; 31(12):1539-1547.
11. Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R. Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS One. 2012;7(1):e29330.
12. MourtzakisM, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol NutrMetab. 2008;33(5):997-1006.
13. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571-578.
14. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27(10):843-850.
15. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AHCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
16. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, LyonsW, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985). 1998;85(1):115-122.
17. Heymsfield SB, McManus CB. Tissue components of weight loss in cancer patients: a new method of study and preliminary observations. Cancer. 1985;55(1)(suppl):238-249.
18. Kvist H, Sjöström L, Tylén U. Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obes. 1986;10(1):53-67.
19. Arrieta O, De la Torre-Vallejo M, López-Macías D, et al. Nutritional status, body surface, and low lean body mass/body mass index are related to dose reduction and severe gastrointestinal toxicity induced by afatinib in patients with non-small cell lung cancer. Oncologist. 2015;20(8):967-974.
20. Cooper JS, Farnan NC, Asbell SO, et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer. 1996;77 (9):1905-1911.
21. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11(1):21-28.
22. Volinsky CT, Raftery AE. Bayesian information criterion for censored survival models. Biometrics. 2000;56(1):256-262.
23. Raftery AE. Bayesian model selection in social research. Sociol Methodol. 1995;25:111-163.
24. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19: 716-723.
25. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15(22):6973-6979.
26. Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005;27(8):659-668.
27. Lønbro S, Dalgas U, Primdahl H, et al. Lean body mass and muscle function in head and neck cancer patients and healthy individuals: results from the DAHANCA 25 study. Acta Oncol. 2013;52 (7):1543-1551.
28. Martin L, Senesse P, Gioulbasanis I, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33 (1):90-99.
29. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factor paradox in wasting diseases. Curr Opin Clin NutrMetab Care. 2007;10(4):433-442.